📰 Mark Swallow News
Page 2 - Mark Swallow News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Swallow. Real-time updates on events, politics, business and more.
December 9, 2022
/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") today announces an update following the Extraordinary General Meeting...
December 9, 2022
/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") today announces an update following the Extraordinary General Meeting...
December 9, 2022
/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") today announces an update following the Extraordinary General Meeting...
December 9, 2022
/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") today announces an update following the Extraordinary General Meeting...
December 9, 2022
OSLO, Norway, Dec. 9, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the...
December 8, 2022
ZURICH, Dec. 8, 2022 /PRNewswire/ -- Anjarium Biosciences AG ("Anjarium"), a biotech company focused on creating and delivering a new class of non-viral gene therapies, today announces the appointment
December 7, 2022
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its gut bacterial Mimicry drug...
November 25, 2022
OSLO, Norway, Nov. 25, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the...
November 25, 2022
/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") has today launched a new dedicated area on its website...
November 22, 2022
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), a leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions...